AbbVie Inc. (ABBV)
@ABBV.asset
$211.96
At close:
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Figures
- Sector Healthcare
- Industry Drug Manufacturers
- Index S&P 500
- Market Cap $374.44 B
- Last Earnings Report Aug 4, 2025
- Price Reaction to Earnings Report 3.76%
- Enterprise Value $438.50 B
- Dividend Yield 0.03%
- P/E ratio 99.63
- Price/Sales ratio 6.43
- EV/Sales ratio 7.52
- Price/Book Value -2716.70
- Revenue $58.33 B
- EBIT $8.26 B
- Net Income $3.76 B
- Gross Profit $41.37 B
- Free Cash Flow $18.24 B
- EBIT Margin 14.17%
- Gross Margin 70.93%
- FCF Margin 31.27%
- Return on Equity -2726.81%
- Equity Ratio -0.10%
- Debt/Equity Ratio -995.07
- 6-month Performance 9.85%
- 12-month Performance 7.81%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |